HIV-positive gay men who have unprotected anal intercourse think of themselves as being in settings where ‘everybody knows the rules of the game’, but these understandings are not shared by all gay men, report Barry Adam and colleagues in... more>

Using the immune-stimulating drug interleukin-2 (IL-2) alongside conventional antiretroviral therapy (ART) can produce a more rapid CD4 increase than usual in people who are... more>

Once-a-day dosing of the newly-licensed non-nucleoside (NNRTI) drug etravirine (TMC125, Intelence) should be sufficient to suppress HIV in patients without NNRTI resistance, the Ninth Congress on Drug Therapy in HIV Infection... more>